150 mg of extract twice a day, before meals.
Signal of weight and waist loss, but the trials are few, small, and from the same group: take it with caution.
View the study (meta-analysis) →Possible lipid improvement, with the same limitation in study quality.
View the study (RCT) →⏱ 3 min read
African mango is Irvingia gabonensis, a tropical tree of West and Central Africa whose seeds (not the fleshy fruit, but the kernels inside the pit) are traditionally eaten as a food thickener and marketed internationally as a supplement for weight loss, glycemic control, and cholesterol reduction; its entry into the global supplement market dates to the mid-2000s, driven by a few Cameroonian clinical trials with notably favorable results that generated considerable commercial expectations.
Unlike other oilseeds used as food, Irvingia seeds are characterized by a very high proportion of soluble fiber and viscous mucilages that, in the gastrointestinal tract, form gels that delay gastric emptying, increase satiety, and modulate the absorption of carbohydrates and fats; this mechanism is consistent with that of other well-studied soluble fibers (psyllium, glucomannan, oat beta-glucans), but the specific clinical effects of Irvingia extract require careful analysis because of the methodological particularities of the available evidence.
The most cited clinical evidence consists of several small Cameroonian trials (especially those by the Ngondi group in 2009) that showed weight loss, reduced waist circumference, and metabolic improvements with doses of 150 milligrams twice daily of standardized extract for 10 weeks, with effect sizes notably larger than usual for weight-loss supplements; these results generated initial enthusiasm but have not been robustly replicated in subsequent independent studies.
A systematic review published in 2013 in the Journal of Dietary Supplements analyzed the available trials and concluded that the evidence on Irvingia for weight loss is methodologically weak, with significant risks of bias and reasonable doubts about whether the effects can be replicated in cohorts other than the original African ones; this conclusion, together with the lack of subsequent rigorous independent trials, has considerably tempered the initial commercial expectations.
Some small studies have shown modest reductions in total cholesterol, LDL, and triglycerides, along with mild improvements in fasting glucose, with supplementation over 8-10 weeks; these effects are consistent with the mechanism of viscous soluble fiber and are comparable (though quantitatively similar or inferior) to those of well-studied and significantly cheaper soluble fibers such as psyllium.
The doses studied are 150 milligrams twice daily (300 mg/day total) of standardized seed extract, taken 30-60 minutes before main meals to maximize the satiating effect; typical commercial products contain 150-500 mg per capsule and vary enormously in origin, standardization, and quality, a heterogeneity that probably contributes to the variability in the clinical results reported.
Generally well tolerated at moderate doses; the most common adverse effects are mild digestive discomfort (flatulence, dyspepsia, headache, occasional sleep disturbances); people with tree nut allergy may have cross-reactions and should use caution; those taking drugs whose absorption may be altered by soluble fiber (some antihypertensives, antidiabetics, anticoagulants, thyroid hormones) should space doses at least 2 hours apart; those taking pharmacological antidiabetic drugs should monitor blood glucose because of a theoretical risk of potentiation; in pregnancy and breastfeeding, data are limited and avoidance is recommended as a precaution; for the clinical goals of satiety, glycemic control, and modest cholesterol reduction, traditional soluble fibers (psyllium, glucomannan, oat beta-glucans) offer a clearly better cost-effectiveness ratio and far more robust clinical evidence.
Information, not medical advice. Scientific evidence reflects the quality of the studies.